Rivastigmine
NL44622.029.13
Approved small_molecule terminated
Quick answer
Rivastigmine for Parkinson's Disease is a Approved program (small_molecule) at Atrium Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Atrium Therapeutics
- Indication
- Parkinson's Disease
- Phase
- Approved
- Modality
- small_molecule
- Status
- terminated